Search

David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP).

… Friday, May 1, 2009 Summary David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). Dr. Scheinberg is a physician-scientist involved in both basic

MSK studies look at the role of RNA splicing factors in acute myeloid leukemia and melanoma.

… Wednesday, October 9, 2019 Summary Two studies looked at the role of specific RNA splicing factors in different cancers. These factors help regulate how proteins are manufactured. Manufacturing proteins is a multistep process that’s hard-coded into how our cells operate. Genes, which are made of DNA,

Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in unexpected ways — ways that have important implications for the development of cancer, researchers at MSK are discovering.

… Tuesday, November 5, 2024 Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in unexpected ways — ways that have important implications for the development of cancer, researchers at Memorial Sloan Kettering Cancer Center (MSK) are discovering

MSK is proud to return as a participant in the 4th Annual Black Health Matters Virtual Summit. Black Health Matters Virtual Summit will provide attendees a chance to interact with physicians, scientists, and advocates, including former First Lady, Michelle Obama, to address equity in all areas of health.

… Wednesday, July 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) is proud to return as a participant in the 4 th Annual Black Health Matters Virtual Summit on Saturday, July 18, from 8:30 a.m. to 6:00 p.m. COVID-19 has created new and unprecedented challenges for patients. This year’s virtual event

MSK is a founding member of the Cancer AI Alliance (CAIA), an exciting collaborative research initiative designed to accelerate development and deployment of AI models to improve cancer care. This unique alliance unites four leading NCI-designated cancer centers — MSK, Dana-Farber Cancer Institute, Fred Hutch Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins — with technology powerhouses that include Ai2, Amazon, Deloitte, Google, Microsoft, Nvidia, and Slalom.

… Wednesday, December 24, 2025 MSK is a founding member of the  Cancer AI Alliance (CAIA) , an exciting collaborative research initiative designed to accelerate development and deployment of AI models to improve cancer care.   This unique alliance unites four leading NCI-designated cancer centers — MSK

Learn how MSK experts are improving the detection and treatment of lung cancer, from fundamental questions of the disease biology to new screening and therapy options.

… Friday, June 6, 2025 Jen Cosgrove says her first appointment at Memorial Sloan Kettering Cancer Cen­ter (MSK) was unforgettable. “When my family and I showed up at MSK, we felt totally defeated,” she says. “We knew I had a type of lung cancer called adenocarcinoma — that was it.” As a wife and mother

May is Clinical Trials Awareness Month, culminating on May 20 with International Clinical Trials Day. For institutions like ours, this is an opportunity to commemorate the importance of clinical research and the valued contributions of clinical research professionals around the world.

… Friday, October 3, 2025 May is Clinical Trials Awareness Month, culminating on May 20 with International Clinical Trials Day. For institutions like ours, this is an opportunity to commemorate the importance of clinical research and the valued contributions of clinical research professionals around the

New MSK research helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; shows the effectiveness of cryoablation for large breast cancer tumors; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.

… Thursday, March 28, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK)  helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; shows the effectiveness of cryoablation for large breast cancer tumors; identifies a gene essential for the formation of

Every day, your commitment to funding life-changing cancer research at Memorial Sloan Kettering is ensuring a brighter future for people with cancer around the world. Thank you for your continued support.

… Thursday, July 1, 2021 Woman with a pom pom at the Cycle for Survival event at MetLife Stadium Cycle for Survival participants gathered at MetLife Stadium in New Jersey on May 1 and 2, 2021, for a socially distanced outdoor ride. Woman with two pom poms on stage at the Cycle for Survival event at MetLife

MSK experts say the Shield blood test is not the best way to detect colorectal cancer and instead recommend colonoscopy or a stool test for those who can’t have a colonoscopy.

… Wednesday, August 13, 2025 Only about two-thirds of the people who should have a  colonoscopy  actually get one. In the quest to improve colorectal cancer screening rates, companies are developing tests that are less invasive. The first blood test to detect  colon cancer and  rectal cancer , called Shield